Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hao Xing

Showing results (1-10 of 303) with videos related to

Pageof 31
Sort By:
European Heart Journal|July 24, 2025
Biomarkers predict cardiovascular outcomes in European cohortHao Xing, Yazhen Su
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 5, 2024
Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer ImmunotherapyHao Xing, Xiaomin Li
Arthritis & Rheumatology (Hoboken, N.J.)|September 1, 2025
JAK inhibitors did not increase the risk of major adverse cardiovascular events in patients with rheumatoid arthritis within the first two years of treatmentHao Xing, Ya-Zhen Su
Journal of Neurosurgery|January 22, 2023
Letter to the Editor. ANOCEF trial: GBMs in elderly patientsBinghao Zhao, Hao Xing, Wenbin Ma
JAMA Surgery|October 5, 2022
Implementation of a Geriatric Trauma Clinical PathwayBinghao Zhao, Hao Xing, Wenbin Ma
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2022
Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Nonsquamous NSCLC Harboring EGFR MutationsBinghao Zhao, Hao Xing, Wenbin Ma
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 22, 2023
Selpercatinib Controls Central Nervous System Disease in Patients With NSCLC With RET FusionBinghao Zhao, Hao Xing, Wenbin Ma
European Urology|April 15, 2023
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116Binghao Zhao, Hao Xing, Wenbin Ma
Organic Letters|May 14, 2014
Supramolecular side-chain poly[2]pseudorotaxanes formed by orthogonal coordination-driven self-assembly and crown-ether-based host-guest interactionsHao Xing, Peifa Wei, Xuzhou Yan
Plos One|September 28, 2023
Effects of different sponge implantation methods of negative pressure wound therapy on wound healing of deep surgical site infection after spinal surgeryJingming Wang, Hao Xing, Zhengqi Chang
Pageof 31

Showing results (1-10 of 303) with videos related to

Sort By:
Pageof 31
European Heart Journal|July 24, 2025
Biomarkers predict cardiovascular outcomes in European cohortHao Xing, Yazhen Su
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 5, 2024
Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer ImmunotherapyHao Xing, Xiaomin Li
Arthritis & Rheumatology (Hoboken, N.J.)|September 1, 2025
JAK inhibitors did not increase the risk of major adverse cardiovascular events in patients with rheumatoid arthritis within the first two years of treatmentHao Xing, Ya-Zhen Su
Journal of Neurosurgery|January 22, 2023
Letter to the Editor. ANOCEF trial: GBMs in elderly patientsBinghao Zhao, Hao Xing, Wenbin Ma
JAMA Surgery|October 5, 2022
Implementation of a Geriatric Trauma Clinical PathwayBinghao Zhao, Hao Xing, Wenbin Ma
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2022
Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Nonsquamous NSCLC Harboring EGFR MutationsBinghao Zhao, Hao Xing, Wenbin Ma
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 22, 2023
Selpercatinib Controls Central Nervous System Disease in Patients With NSCLC With RET FusionBinghao Zhao, Hao Xing, Wenbin Ma
European Urology|April 15, 2023
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116Binghao Zhao, Hao Xing, Wenbin Ma
Organic Letters|May 14, 2014
Supramolecular side-chain poly[2]pseudorotaxanes formed by orthogonal coordination-driven self-assembly and crown-ether-based host-guest interactionsHao Xing, Peifa Wei, Xuzhou Yan
Plos One|September 28, 2023
Effects of different sponge implantation methods of negative pressure wound therapy on wound healing of deep surgical site infection after spinal surgeryJingming Wang, Hao Xing, Zhengqi Chang
Pageof 31